<?xml version="1.0" encoding="UTF-8"?>
<ref id="B43-biomedicines-08-00109">
 <label>43.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhao</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Jha</surname>
    <given-names>B.K.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Elliott</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Ziebuhr</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gorbalenya</surname>
    <given-names>A.E.</given-names>
   </name>
   <name>
    <surname>Silverman</surname>
    <given-names>R.H.</given-names>
   </name>
   <name>
    <surname>Weiss</surname>
    <given-names>S.R.</given-names>
   </name>
  </person-group>
  <article-title>Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology</article-title>
  <source>Cell. Host Microbe</source>
  <year>2012</year>
  <volume>11</volume>
  <fpage>607</fpage>
  <lpage>616</lpage>
  <pub-id pub-id-type="doi">10.1016/j.chom.2012.04.011</pub-id>
  <?supplied-pmid 22704621?>
  <pub-id pub-id-type="pmid">22704621</pub-id>
 </element-citation>
</ref>
